CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2007-12-03): Hepatitis B vaccination not tied to MS in children

Clinical

Hepatitis B vaccination not tied to MS in children

Last Updated: 2007-12-03 16:00:38 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Immunization with the recombinant hepatitis B vaccine (HBV) does not increase the risk of childhood-onset MS (MS), according to a report in the Archives of Pediatrics and Adolescent Medicine for December.

Most prior studies have not shown a link between the use of HBV and MS in children. However, one study, which featured a slightly longer follow-up period than the others, did suggest a significant association. This led to public concerns about the safety of HBV and a drop in vaccination rates in many countries.

Furthermore, many of the earlier studies had methodologic limitations, such as limited statistical power and non-validation of vaccination, which may have prevented them from reaching definitive conclusions, lead author Dr. Yann Mikaeloff, from Hopital Bicetre, Le Kremlin Bicetre, and colleagues note.

The present case-control study, which was conducted in France between January 1994 and December 2003, involved 143 patients who developed MS before the age of 16 years and 1,122 matched controls without MS.

The HBV vaccination rates in the 3 years before the index date (first episode of MS) were nearly the same in the case and control groups, roughly 32%.

There was no evidence that vaccination within 6 months of the index date increased the risk of disease, and neither the number of HBV injections nor the brand of vaccine used seemed to have any effect.

In a related editorial, Dr. Frederick P. Rivara and Dr. Dimitri A. Christakis, at the University of Washington and editors at the Archives of Pediatrics and Adolescent Medicine, comment: "We have published (this study) both because of the rigor of the research and because of the need to reassure a public that is increasingly wary of vaccination."

"Going forward, we hope that the process of scientific discovery proceeds in a rigorous and thoughtful way that will increase the public's health and not harm it."

Arch Pediatr Adolesc Med 2007;161:1176-1182,1214-1215.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.